Cordis Global Medical Technology

ETL4642AU

Cordis Global Medical Technology ETL4642AU Strategy

The Fund follows a fundamental long-only active strategy. Cordis runs a high conviction actively managed specialised portfolio, limited to between 20-40 stocks selected from the medical technology sub-sector of listed global healthcare companies.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.

Funds News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,637.8012.900.15%
CAC 407,817.4729.370.38%
DAX 4024,048.6010.410.04%
Dow JONES (US)42,098.70244.95-0.58%
FTSE 1008,742.6816.670.19%
HKSE23,573.38315.071.35%
NASDAQ19,100.9498.22-0.51%
Nikkei 22538,432.98710.581.88%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,888.550.000.00%
S&P/ASX 2008,409.8012.900.15%
SSE Composite Index3,363.4523.510.70%

Market Movers